Patent · US Active

Transdermal therapeutic system containing asenapine

US10898449B2 · kind B2 · utility

5Cited by
85References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 11, 2020
Grant dateJan 26, 2021
Priority date
Expiry dateFeb 11, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to transdermal therapeutic systems (TTS) for the transdermal administration of asenapine comprising a self-adhesive layer structure containing a therapeutically effective amount of asenapine, such asenapine TTS for use in a method of treatment, processes of manufacture of such TTS as well as asenapine and transdermal therapeutic systems containing asenapine for use in a method of treatment and to a method of treating a human patient by transdermal administration of asenapine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.